Literature DB >> 8484099

Multicentric Castleman's disease in a patient with primary Sjögren's syndrome.

A Tavoni1, C Vitali, P Baglioni, R Gerli, G Marchetti, O Di Munno, S Bombardieri.   

Abstract

A 38-year-old woman suffering from primary Sjögren's syndrome for 2 years developed angiofollicular hyperplasia (multicentric Castleman's disease). In Sjögren's syndrome (SS) a number of findings indicate the presence of a B-cell hyperactivity that may evolve to a lymphoproliferative disorder. This report adds another pathological event to the complex spectrum of lymphoproliferative diseases in SS.

Entities:  

Mesh：

Year:  1993        PMID： 8484099     DOI： 10.1007/bf00301012

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  17 in total

1.  Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases.

Authors:  D D Weisenburger; B N Nathwani; C D Winberg; H Rappaport
Journal:  Hum Pathol       Date:  1985-02       Impact factor: 3.466

2.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

3.  Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant.

Authors:  T Radaszkiewicz; M L Hansmann; K Lennert
Journal:  Histopathology       Date:  1989-01       Impact factor: 5.087

4.  Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors:  A R Keller; L Hochholzer; B Castleman
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

5.  Letter: Sjögren's syndrome with light chain myeloma.

Authors:  M A Shearn; H M Moutsopoulos; S Sawada; C Gak
Journal:  West J Med       Date:  1975-12

6.  [Angioimmunoblastic lymphadenopathy (AIL) rich in epithelioid cells presenting a Gougerot-Sjögren syndrome. Nosological relationship between Sjörgen "pseudolymphomas" and AIL (a case with a fatal course)].

Authors:  Y Le Charpentier; J N Faucher; R Ghozlan; F Delbarre; A Louvel; G Lemaigre; M C Vacher-Lavenu; B Amor; R Abelanet
Journal:  Ann Anat Pathol (Paris)       Date:  1978

7.  Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome.

Authors:  R I Fox; T C Adamson; S Fong; C A Robinson; E L Morgan; J A Robb; F V Howell
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients.

Authors:  G Frizzera; P M Banks; G Massarelli; J Rosai
Journal:  Am J Surg Pathol       Date:  1983-04       Impact factor: 6.394

9.  A plasma cell granuloma in a patient with Sjögren's syndrome.

Authors:  C Vitali; A Tavoni; U Simi; G Viegi; S Bombardieri
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

10.  Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia).

Authors:  N Talal; L Sokoloff; W F Barth
Journal:  Am J Med       Date:  1967-07       Impact factor: 4.965
View more
  2 in total

1.  Interleukin-6-producing dermoid cyst associated with multicentric Castleman's disease.

Authors:  Shigeyuki Ebara; Soken-Nakazawa J Song; Hiroyuki Mizuta; Yasushi Ito; Kenji Hasegawa; Tsuneko Kamata; Teppei Matsumura-Nishikawa; Takafumi Ogawa; Jyunichi Soneda; Kazuyuki Yoshizaki
Journal:  Int J Hematol       Date:  2011-12-14       Impact factor: 2.490

2.  Sjögren's and plasma cell variant Castleman disease: a case report.

Authors:  Yvonne A Dei-Adomakoh; Leslie Quarcoopome; Afua D Abrahams; Catherine I Segbefia; Dzifa I Dey
Journal:  Ghana Med J       Date:  2018-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.